title: Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy.
abstract: Mice lacking Kv1.1 Shaker-like potassium channels encoded by the Kcna1 gene exhibit severe seizures and die prematurely. The channel is widely expressed in brain but only minimally, if at all, in mouse myocardium. To test whether Kv1.1-potassium deficiency could underlie primary neurogenic cardiac dysfunction, we performed simultaneous video EEG-ECG recordings and found that Kcna1-null mice display potentially malignant interictal cardiac abnormalities, including a fivefold increase in atrioventricular (AV) conduction blocks, as well as bradycardia and premature ventricular contractions. During seizures the occurrence of AV conduction blocks increased, predisposing Kv1.1-deficient mice to sudden unexplained death in epilepsy (SUDEP), which we recorded fortuitously in one animal. To determine whether the interictal AV conduction blocks were of cardiac or neural origin, we examined their response to selective pharmacological blockade of the autonomic nervous system. Simultaneous administration of atropine and propranolol to block parasympathetic and sympathetic branches, respectively, eliminated conduction blocks. When administered separately, only atropine ameliorated AV conduction blocks, indicating that excessive parasympathetic tone contributes to the neurocardiac defect. We found no changes in Kv1.1-deficient cardiac structure, but extensive Kv1.1 expression in juxtaparanodes of the wild-type vagus nerve, the primary source of parasympathetic input to the heart, suggesting a novel site of action leading to Kv1.1-associated cardiac bradyarrhythmias. Together, our data suggest that Kv1.1 deficiency leads to impaired neural control of cardiac rhythmicity due in part to aberrant parasympathetic neurotransmission, making Kcna1 a strong candidate gene for human SUDEP.
authors.affiliation: Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.
authors.forename: Edward
authors.initials: E
authors.lastname: Glasscock
authors.forename: Jong W
authors.initials: JW
authors.lastname: Yoo
authors.forename: Tim T
authors.initials: TT
authors.lastname: Chen
authors.forename: Tara L
authors.initials: TL
authors.lastname: Klassen
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Noebels
mesh_terms: D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000503:physiopathology*; D054537:Atrioventricular Block / Q000188:drug therapy / Q000503:physiopathology; D001285:Atropine / Q000494:pharmacology; D001919:Bradycardia / Q000188:drug therapy / Q000503:physiopathology; D001921:Brain / Q000503:physiopathology*; D004562:Electrocardiography / Q000379:methods; D004569:Electroencephalography / Q000379:methods; D006321:Heart / Q000187:drug effects / Q000503:physiopathology*; D051662:Kv1.1 Potassium Channel / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D010276:Parasympatholytics / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012640:Seizures / Q000503:physiopathology*; D014630:Vagus Nerve / Q000378:metabolism; D018879:Ventricular Premature Complexes / Q000188:drug therapy / Q000503:physiopathology; D014741:Video Recording / Q000379:methods
chemical_list: D000889:Anti-Arrhythmia Agents; C496947:Kcna1 protein, mouse; D010276:Parasympatholytics; D051662:Kv1.1 Potassium Channel; D001285:Atropine; D011433:Propranolol
references.citation: Circ Res. 2001 May 11;88(9):940-6
references.pmid: 11349004
references.citation: Physiol Genomics. 2007 Feb 12;28(3):273-83
references.pmid: 16985003
references.citation: Physiol Rev. 2005 Oct;85(4):1205-53
references.pmid: 16183911
references.citation: Epilepsia. 2004 Dec;45(12):1640-4
references.pmid: 15571524
references.citation: Dev Neurosci. 1999 Nov;21(3-5):320-7
references.pmid: 10575255
references.citation: Brain. 1999 May;122 ( Pt 5):817-25
references.pmid: 10355668
references.citation: J Neurophysiol. 2006 Apr;95(4):2032-41
references.pmid: 16306173
references.citation: Cleve Clin J Med. 2008 Mar;75 Suppl 2:S66-70
references.pmid: 18540150
references.citation: Neuron. 1998 Apr;20(4):809-19
references.pmid: 9581771
references.citation: Seizure. 2009 Jul;18(6):457-61
references.pmid: 19414273
references.citation: BMJ. 2002 Mar 2;324(7336):535-8
references.pmid: 11872557
references.citation: J Neurosci. 1998 Sep 15;18(18):7200-15
references.pmid: 9736643
references.citation: J Physiol. 2007 Jul 15;582(Pt 2):675-93
references.pmid: 17478540
references.citation: Nat Med. 2007 May;13(5):604-12
references.pmid: 17417650
references.citation: Arch Neurol. 1986 Feb;43(2):194-6
references.pmid: 3947265
references.citation: Neurology. 1997 Jun;48(6):1712-4
references.pmid: 9191793
references.citation: Am J Physiol. 1998 Mar;274(3):H747-51
references.pmid: 9530184
references.citation: Epilepsy Behav. 2006 Aug;9(1):19-30
references.pmid: 16809068
references.citation: J Neurosci. 1999 Jul 15;19(14):5768-81
references.pmid: 10407018
references.citation: J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):211-3
references.pmid: 10644790
references.citation: J Clin Invest. 2003 Feb;111(3):341-6
references.pmid: 12569159
references.citation: Neurology. 2009 Jan 20;72(3):224-31
references.pmid: 19038855
references.citation: J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):734-6
references.pmid: 1527551
references.citation: Brain Res. 2006 Mar 17;1078(1):1-8
references.pmid: 16492381
references.citation: Nat Rev Neurol. 2009 Sep;5(9):492-504
references.pmid: 19668244
references.citation: Biochem Biophys Res Commun. 2009 Mar 27;381(1):27-32
references.pmid: 19351589
references.citation: J Physiol. 2005 Jan 1;562(Pt 1):223-34
references.pmid: 15498808
references.citation: J Neurosci. 1995 May;15(5 Pt 2):3761-74
references.pmid: 7751944
references.citation: Am J Physiol Heart Circ Physiol. 2006 Nov;291(5):H2187-91
references.pmid: 16766645
references.citation: Histochem Cell Biol. 2010 Mar;133(3):301-12
references.pmid: 20012645
references.citation: Neurology. 1998 Nov;51(5):1270-4
references.pmid: 9818844
references.citation: Trends Neurosci. 2004 Apr;27(4):210-7
references.pmid: 15046880
references.citation: Epilepsia. 1996 Oct;37(10):983-7
references.pmid: 8822697
references.citation: Physiol Genomics. 2005 Dec 14;24(1):4-12
references.pmid: 16219869
references.citation: Epilepsia. 2003 Dec;44(12):1506-12
references.pmid: 14636320
references.citation: Nat Neurosci. 2007 Dec;10(12):1554-8
references.pmid: 17982453
references.citation: Epilepsia. 2007 May;48(5):859-71
references.pmid: 17433051
references.citation: J Neurocytol. 1999 Apr-May;28(4-5):349-64
references.pmid: 10739576
references.citation: J Neurol Neurosurg Psychiatry. 2000 Oct;69(4):557-9
references.pmid: 10990526
references.citation: Neuron. 1995 Dec;15(6):1449-54
references.pmid: 8845167
references.citation: Brain. 2001 Dec;124(Pt 12):2361-71
references.pmid: 11701591
references.citation: Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H1057-65
references.pmid: 11514271
references.citation: Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2076-83
references.pmid: 12003814
references.citation: Acta Neurol Scand. 2002 Oct;106(4):229-33
references.pmid: 12225321
references.citation: Sci Transl Med. 2009 Oct 14;1(2):2ra6
references.pmid: 20368164
references.citation: Circ Res. 1994 Aug;75(2):252-60
references.pmid: 8033339
references.citation: Auton Neurosci. 2000 Dec 20;85(1-3):1-17
references.pmid: 11189015
references.citation: J Neurophysiol. 1964 Sep;27:893-912
references.pmid: 14205010
references.citation: Br J Pharmacol. 1995 Sep;116(1):1577-82
references.pmid: 8564221
references.citation: J Neurosci. 1994 Aug;14(8):4588-99
references.pmid: 8046438
references.citation: Lancet. 2004 Dec 18-31;364(9452):2212-9
references.pmid: 15610808
references.citation: Muscle Nerve. 2001 May;24(5):630-3
references.pmid: 11317272
references.citation: Epilepsia. 2007 Nov;48(11):2023-46
references.pmid: 17651419